MedPath
NMPA Approval

Golimumab Injection

国药准字SJ20202003

October 10, 2024

S20170050

Drug Information

戈利木单抗注射液

欣普尼

欣普尼

注射剂

50mg(0.5ml)/支(预充笔式注射器)

生物制品

October 10, 2024

October 9, 2029

Company Information

Applicant Company

Einsteinweg 101, 2333 CB Leiden, The Netherlands

Manufacturing Company

Cilag AG

Hochstrasse 201, CH-8200 Schaffhausen, Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

戈利木单抗注射液 - NMPA 批准文号 | MedPath